These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 8487325

  • 1. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.
    Wolf DM, Langan-Fahey SM, Parker CJ, McCague R, Jordan VC.
    J Natl Cancer Inst; 1993 May 19; 85(10):806-12. PubMed ID: 8487325
    [Abstract] [Full Text] [Related]

  • 2. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May 19; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 3. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
    Osipo C, Gajdos C, Cheng D, Jordan VC.
    J Steroid Biochem Mol Biol; 2005 Feb 19; 93(2-5):249-56. PubMed ID: 15860267
    [Abstract] [Full Text] [Related]

  • 4. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
    Lee ES, Schafer JM, Yao K, England G, O'Regan RM, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2000 Dec 19; 6(12):4893-9. PubMed ID: 11156249
    [Abstract] [Full Text] [Related]

  • 5. The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth.
    Osborne CK, Jarman M, McCague R, Coronado EB, Hilsenbeck SG, Wakeling AE.
    Cancer Chemother Pharmacol; 1994 Dec 19; 34(2):89-95. PubMed ID: 8194171
    [Abstract] [Full Text] [Related]

  • 6. Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice.
    Wolf DM, Jordan VC.
    Breast Cancer Res Treat; 1994 Dec 19; 31(1):117-27. PubMed ID: 7981452
    [Abstract] [Full Text] [Related]

  • 7. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC.
    Cancer Res; 1988 Feb 15; 48(4):812-5. PubMed ID: 3338079
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
    Gottardis MM, Jiang SY, Jeng MH, Jordan VC.
    Cancer Res; 1989 Aug 01; 49(15):4090-3. PubMed ID: 2743303
    [Abstract] [Full Text] [Related]

  • 9. Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.
    Gottardis MM, Wagner RJ, Borden EC, Jordan VC.
    Cancer Res; 1989 Sep 01; 49(17):4765-9. PubMed ID: 2758410
    [Abstract] [Full Text] [Related]

  • 10. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.
    Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG.
    Cancer Res; 2002 May 01; 62(9):2474-7. PubMed ID: 11980635
    [Abstract] [Full Text] [Related]

  • 11. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC, Gottardis MM, Robinson SP, Friedl A.
    J Steroid Biochem; 1989 May 01; 34(1-6):169-76. PubMed ID: 2626014
    [Abstract] [Full Text] [Related]

  • 12. Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endometrial carcinoma (EnCa101) in athymic mice.
    Gottardis MM, Ricchio ME, Satyaswaroop PG, Jordan VC.
    Cancer Res; 1990 Jun 01; 50(11):3189-92. PubMed ID: 2334915
    [Abstract] [Full Text] [Related]

  • 13. Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.
    Gibson DF, Johnson DA, Goldstein D, Langan-Fahey SM, Borden EC, Jordan VC.
    Breast Cancer Res Treat; 1993 Jun 01; 25(2):141-50. PubMed ID: 8347846
    [Abstract] [Full Text] [Related]

  • 14. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.
    Brünner N, Bronzert D, Vindeløv LL, Rygaard K, Spang-Thomsen M, Lippman ME.
    Cancer Res; 1989 Mar 15; 49(6):1515-20. PubMed ID: 2924304
    [Abstract] [Full Text] [Related]

  • 15. The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain.
    Wolf DM, Jordan VC.
    Breast Cancer Res Treat; 1994 Mar 15; 31(1):129-38. PubMed ID: 7981453
    [Abstract] [Full Text] [Related]

  • 16. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration.
    Gottardis MM, Jordan VC.
    Cancer Res; 1988 Sep 15; 48(18):5183-7. PubMed ID: 3409244
    [Abstract] [Full Text] [Related]

  • 17. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.
    Schafer JM, Lee ES, O'Regan RM, Yao K, Jordan VC.
    Clin Cancer Res; 2000 Nov 15; 6(11):4373-80. PubMed ID: 11106256
    [Abstract] [Full Text] [Related]

  • 18. Regulation of estrogen receptor and epidermal growth factor receptor by tamoxifen under high and low estrogen environments in MCF-7 cells grown in athymic mice.
    Koibuchi Y, Iino Y, Uchida T, Andoh T, Horii Y, Nagasawa M, Horiguchi J, Maemura M, Takei H, Yokoe T, Morishita Y.
    Oncol Rep; 2000 Nov 15; 7(1):135-40. PubMed ID: 10601607
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms for tamoxifen resistance in breast cancer: possible role of tamoxifen metabolism.
    Osborne CK.
    J Steroid Biochem Mol Biol; 1993 Dec 15; 47(1-6):83-9. PubMed ID: 8274445
    [Abstract] [Full Text] [Related]

  • 20. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2002 Jun 15; 8(6):1995-2001. PubMed ID: 12060645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.